Skip to Content
Amir Ali Rahnemai Azar, MD

Contact Dr. Rahnemai Azar


Amir Ali Rahnemai Azar, MD

Complex General Surgical Oncology Fellow


  • MD, Shahid Beheshti University of Medical Sciences, Tehran, Iran, 2003
  • General Surgery Residency, Albert Einstein College of Medicine, NY
  • Abdominal Organ Transplantation Fellowship, University of Washington, WA

Research Interests

Recent Publications
  • Postoperative Abdominal Adhesions: Clinical Significance and Advances in Prevention and Management.
    Moris D, Chakedis J, Rahnemai-Azar AA, Wilson A, Hennessy MM, Athanasiou A, Beal EW, Argyrou C, Felekouras E, Pawlik TM
    J. Gastrointest. Surg. 2017 Jul 06.
    [PubMed ID: 28685387]
    More Information
  • Clinical Impact and Risk Factors of Portal Vein Thrombosis for Patients on Wait List for Liver Transplant.
    Montenovo M, Rahnemai-Azar A, Reyes J, Perkins J
    Exp Clin Transplant 2017 Jun 16.
    [PubMed ID: 28621635]
    More Information
  • Current Management of Perihilar Cholangiocarcinoma and Future Perspectives.
    Lewis HL, Rahnemai-Azar AA, Dillhoff M, Schmidt CR, Pawlik TM
    Chirurgia (Bucur) 2017 May-Jun; 112(3):193-207.
    [PubMed ID: 28675356]
    More Information
  • Parenchymal-Sparing Versus Anatomic Liver Resection for Colorectal Liver Metastases: a Systematic Review.
    Moris D, Ronnekleiv-Kelly S, Rahnemai-Azar AA, Felekouras E, Dillhoff M, Schmidt C, Pawlik TM
    J. Gastrointest. Surg. 2017 Jun; 21(6):1076-1085.
    [PubMed ID: 28364212]
    More Information
  • Intrahepatic cholangiocarcinoma: current management and emerging therapies.
    Rahnemai-Azar AA, Weisbrod AB, Dillhoff M, Schmidt C, Pawlik TM
    Expert Rev Gastroenterol Hepatol 2017 May; 11(5):439-449.
    [PubMed ID: 28317403]
    More Information
  • Intrahepatic cholangiocarcinoma: Molecular markers for diagnosis and prognosis.
    Rahnemai-Azar AA, Weisbrod A, Dillhoff M, Schmidt C, Pawlik TM
    Surg Oncol 2017 Jun; 26(2):125-137.
    [PubMed ID: 28577718]
    More Information
  • Penile Replantation: A Retrospective Analysis of Outcomes and Complications.
    Morrison SD, Shakir A, Vyas KS, Remington AC, Mogni B, Wilson SC, Grant DW, Cho DY, Rahnemai-Azar AA, Lee GK, Friedrich JB, Mardini S
    J Reconstr Microsurg 2017 May; 33(4):227-232.
    [PubMed ID: 28002849]
    More Information
  • Landscape of Kidney Transplantation in Patients With Compensated Liver Disease: Results of a Survey of Transplant Surgeons in the United States.
    Sibulesky L, Hansen RN, Leca N, Blosser C, Rahnemai-Azar AA, Montenovo MI, Dick AA, Bakthavatsalam R, Rayhill S, Bhattacharya R, Reyes JD
    Transplant. Proc. 2016 Dec; 48(10):3268-3273.
    [PubMed ID: 27931567]
    More Information
  • Is MELD score failing patients with liver disease and hepatorenal syndrome?
    Sibulesky L, Leca N, Blosser C, Rahnemai-Azar AA, Bhattacharya R, Reyes J
    World J Hepatol 2016 Sep 28; 8(27):1155-1156.
    [PubMed ID: 27721921, PMC ID: 5037329]
    More Information
  • Realistic Survival Outcomes After Vasopressor Use in the Intensive Care Unit.
    Farkas DT, Rahnemai-Azar AA, Kunhammed SS, Greenbaum A, Bibi S, John MM
    Am J Hosp Palliat Care 2016 Nov; 33(9):871-874.
    [PubMed ID: 26113743]
    More Information Copyright © 2017 The Board of Regents of the University of Wisconsin System